Tolvaptan a possible adjunct treatment for heart failure

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1582-1583, 2007-01, pp. : 5-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tolvaptan for the treatment of heart failure: a review of the literature

By Ambrosy Andrew   Goldsmith Steven R   Gheorghiade Mihai  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 6, 2011-04 ,pp. : 961-976

Informa Healthcare

Access to resources Recommend Favorite

Tolvaptan Offers an Alternative to Diuretics for Congestive Heart Failure

By  

Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 1, 2004-05 ,pp. : 23-25

Adis International

Access to resources Recommend Favorite

V2 receptor antagonism with tolvaptan in heart failure

By Costello-Boerrigter Lisa C   Boerrigter Guido   Burnett John C  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1639-1647

Informa Healthcare

Access to resources Recommend Favorite

Impaired Glucose Metabolism in Patients with Heart Failure: Pathophysiology and Possible Treatment Strategies

By Alexander Tenenbaum   Enrique Z. Fisman  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 5, 2004-01 ,pp. : 269-280

Adis International

Access to resources Recommend Favorite

Valsartan for the treatment of heart failure

By Latini Roberto   Masson Serge   Staszewsky Lidia   Maggioni Aldo P  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 181-193

Informa Healthcare

Access to resources Recommend Favorite